Companies / Celldex Therapeutics, Inc. / Activity
Activity — Celldex Therapeutics, Inc.
6 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Martin Samuel Bates Executive | Exercise | Common Stock | $50.0K | +5K +17.13% | 32,942 0.04% of shares | low |
| Jun 25, 2026 | Conrad Herbert J Director | Grant | Non-Qualified Stock Option (right to buy) | — | +26K | 26,000 0.03% of shares | low |
| Jun 25, 2026 | Pepin Ronald Executive | Grant | Incentive Stock Option (right to buy) | — | +20K | 20,000 0.03% of shares | low |
| Jun 25, 2026 | Marino James J Director | Grant | Non-Qualified Stock Option (right to buy) | — | +26K | 26,000 0.03% of shares | low |
| Jun 25, 2026 | Penner Harry Jr Director | Grant | Non-Qualified Stock Option (right to buy) | — | +26K | 26,000 0.03% of shares | low |
| Jan 2, 2026 | Martin Samuel Bates Executive | Exercise | Incentive Stock Option (Right to Buy) | — | -5K -7.57% | 58,815 0.07% of shares | low |